Yu Lou
Zhejiang Chinese Medical University(CN)Hunan University(CN)Shenzhen University(CN)Anhui University of Science and Technology(CN)Chinese Academy of Sciences(CN)Henan University of Technology(CN)Nanjing University of Science and Technology(CN)Integrated Optoelectronics (Norway)(NO)Anhui Science and Technology University(CN)China Academy of Chinese Medical Sciences(CN)Shenzhen Institutes of Advanced Technology(CN)Shenzhen Technology University(CN)First Affiliated Hospital Zhejiang University(CN)State Key Laboratory of Chemobiosensing and Chemometrics
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Pneumocystis jirovecii pneumonia detection and treatment, HIV/AIDS Research and Interventions, Hepatitis C virus research
Most-Cited Works
- → Colonization with group B streptococci in pregnancy and adverse outcome(1996)302 cited
- → Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers(2009)239 cited
- → Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans(2013)136 cited
- → Pharmacokinetics, Safety, and Tolerability With Repeat Doses of GSK1265744 and Rilpivirine (TMC278) Long-Acting Nanosuspensions in Healthy Adults(2014)114 cited
- → Pharmacokinetics, Safety, and Monotherapy Antiviral Activity of GSK1265744, an HIV Integrase Strand Transfer Inhibitor(2013)112 cited
- → Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults(2005)111 cited